These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11771869)

  • 1. Abnormal rheology in cyanotic congenital heart disease--a factor in non-immune nephropathy.
    Dittrich S; Kurschat K; Lange PE
    Scand J Urol Nephrol; 2001 Oct; 35(5):411-5. PubMed ID: 11771869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease.
    Dittrich S; Kurschat K; Dähnert I; Vogel M; Müller C; Lange PE
    Cardiol Young; 2000 Jan; 10(1):8-14. PubMed ID: 10695534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
    Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
    J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer.
    Katayama Y; Horigome H; Murakami T; Takahashi-Igari M; Miyata D; Tanaka K
    Clin Hemorheol Microcirc; 2006; 35(4):499-508. PubMed ID: 17148849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic changes in children with cyanotic and acyanotic congenital heart disease.
    Goel M; Shome DK; Singh ZN; Bhattacharjee J; Khalil A
    Indian Heart J; 2000; 52(5):559-63. PubMed ID: 11256779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between vascular endothelial growth factor and leptin in children with cyanotic congenital heart disease.
    Aydin HI; Yozgat Y; Demirkaya E; Olgun A; Okutan V; Lenk MK; Ozcan O
    Turk J Pediatr; 2007; 49(4):360-4. PubMed ID: 18246735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.
    Hongsawong N; Khamdee P; Silvilairat S; Chartapisak W
    Pediatr Nephrol; 2018 Mar; 33(3):493-501. PubMed ID: 28971258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease.
    Dittrich S; Kurschat K; Dähnert I; Vogel M; Müller C; Alexi-Meskishvili V; Lange PE
    Int J Cardiol; 2000 Apr; 73(2):173-9. PubMed ID: 10817857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oxidative state of children with cyanotic and acyanotic congenital heart disease.
    Ercan S; Cakmak A; Kösecik M; Erel O
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):486-90. PubMed ID: 19965321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters.
    Hallioglu O; Alehan D; Kandemir N
    Int J Cardiol; 2003 Nov; 92(1):93-7. PubMed ID: 14602223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease.
    Hopkins WE; Hall C
    Circulation; 1997 Oct; 96(7):2215-20. PubMed ID: 9337192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of renal function between cyanotic and acyanotic congenital heart disease in children and adolescent.
    Amornchaicharoensuk Y; Werawatganon T; Tohsukhowong P; Boonla C; Gengsakul A; Tarunotai T; Samankatiwat P; Treewatchareekorn M
    J Med Assoc Thai; 2012 Dec; 95(12):1501-8. PubMed ID: 23390779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease.
    Rosenthal A; Nathan DG; Marty AT; Button LN; Miettinen OS; Nadas AS
    Circulation; 1970 Aug; 42(2):297-308. PubMed ID: 5431926
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of sevoflurane anesthesia and cardiopulmonary bypass on renal function in cyanotic and acyanotic children undergoing cardiac surgery.
    Oc B; Akinci SB; Kanbak M; Satana E; Celebioglu B; Aypar U
    Ren Fail; 2012; 34(2):135-41. PubMed ID: 22150502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thixotropic properties of whole blood in children with congenital heart disease].
    Li L; Chen H; Zhong G; Yang Y; Tang S; Zhang F; Zhou T; Wang M; Huo Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):137-9. PubMed ID: 1452142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-Selectin and Asymmetric Dimethylarginine Levels in Adult Cyanotic Congenital Heart Disease: Their Relation to Biochemical Parameters, Vascular Function, and Clinical Status.
    Nartowicz SA; Szczepaniak-Chicheł L; Lipski D; Miechowicz I; Bartczak-Rutkowska A; Gabriel M; Lesiak M; Trojnarska O
    Cells; 2024 Sep; 13(17):. PubMed ID: 39273064
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of ghrelin and insulin-like growth factor-1 in immature piglet model of chronic cyanotic congenital heart defects with decreased pulmonary blood flow.
    Wang D; Liu YL; Lü XD; Zhu YB; Ling F; Liu AJ; Li G; Xu YL
    Chin Med J (Engl); 2011 Aug; 124(15):2354-60. PubMed ID: 21933568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic growth factors in patients with cyanotic congenital heart disease and in normal children.
    Himeno W
    Kurume Med J; 2001; 48(2):111-6. PubMed ID: 11501491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
    Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
    Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.